SciCombinator

Discover the most talked about and latest scientific content & concepts.

ZY Zhao, XJ Xie, WH Li, J Liu, Z Chen, B Zhang, T Li, SL Li, JG Lu, L Zhang, LH Zhang, Z Xu, HC Lee and YJ Zhao
Abstract
SARM1, an NAD-utilizing enzyme, regulates axonal degeneration. We show that CZ-48, a cell-permeant mimetic of NMN, activated SARM1 in vitro and in cellulo to cyclize NAD and produce a Ca2+ messenger, cADPR, with similar efficiency as NMN. Knockout of NMN-adenylyltransferase elevated cellular NMN and activated SARM1 to produce cADPR, confirming NMN was its endogenous activator. Determinants for the activating effects and cell permeability of CZ-48 were identified. CZ-48 activated SARM1 via a conformational change of the auto-inhibitory domain and dimerization of its catalytic domain. SARM1 catalysis was similar to CD38, despite having no sequence similarity. Both catalyzed similar set of reactions, but SARM1 had much higher NAD-cyclizing activity, making it more efficient in elevating cADPR. CZ-48 acted selectively, activating SARM1 but inhibiting CD38. In SARM1-overexpressing cells, CZ-48 elevated cADPR, depleted NAD and ATP, and induced non-apoptotic death. CZ-48 is a specific modulator of SARM1 functions in cells.
Tweets*
10
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
4
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com